DURHAM, N.C.--(BUSINESS WIRE)--Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that an abstract reporting results from the company’s Tryton stent system was recognized as the best presented at the Italian Society of Interventional Cardiology National Congress (GISE) in Genoa, Italy.
